# Chongqing Kangle Pharmaceutical Co., Ltd - Inspection Records

Source: https://www.globalkeysolutions.net/companies/chongqing-kangle-pharmaceutical-co-ltd/10ee20e7-7e03-4bf3-835f-53e9c3c8ebfc

> Inspection records and compliance data for Chongqing Kangle Pharmaceutical Co., Ltd in Chongqing, None. Access full analysis and detailed observations.

---

## Details

- Name: Chongqing Kangle Pharmaceutical Co., Ltd
- FEI Number: 3007088564
- City: Chongqing
- State: None
- Country Name: China
- Address Line 1: (Changshou) Chemical Ind. Park, No 4 Huazhong Road, Chongqing
- Zip Code: None
- Business Operations: API MANUFACTURE

## Related Documents

- [FDA Inspection 1286254 - Chongqing Kangle Pharmaceutical Co., Ltd - 2025-09-05](https://www.globalkeysolutions.net/records/fda_inspections/chongqing-kangle-pharmaceutical-co-ltd/0ae9e965-0baa-4ae0-ae7f-b42f8e6e62b6) — source: FDA, date: September 5, 2025
- [FDA Inspection 1286254 - Chongqing Kangle Pharmaceutical Co., Ltd - 2025-09-05](https://www.globalkeysolutions.net/records/fda_inspections/chongqing-kangle-pharmaceutical-co-ltd/f472c43f-66a2-4465-bada-478e10786dfb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 5, 2025
- [FDA Inspection 1064345 - Chongqing Kangle Pharmaceutical Co., Ltd - 2018-07-26](https://www.globalkeysolutions.net/records/fda_inspections/chongqing-kangle-pharmaceutical-co-ltd/d6272298-6c9d-42d7-b3ad-95df1968b5f5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 26, 2018
- [483 - Chongqing Kangle Pharmaceutical Co., Ltd - 2018-07-23](https://www.globalkeysolutions.net/records/483/chongqing-kangle-pharmaceutical-co-ltd/d8415090-ab91-4e96-82df-e1fd011c3335) — source: FDA, date: July 23, 2018
- [FDA Inspection 912714 - Chongqing Kangle Pharmaceutical Co., Ltd - 2015-01-30](https://www.globalkeysolutions.net/records/fda_inspections/chongqing-kangle-pharmaceutical-co-ltd/47fa1765-dc36-46a3-a511-6e7f84be0127) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 30, 2015
- [FDA Inspection 783920 - Chongqing Kangle Pharmaceutical Co., Ltd - 2012-04-26](https://www.globalkeysolutions.net/records/fda_inspections/chongqing-kangle-pharmaceutical-co-ltd/c8958ba3-b423-403c-9aec-68f94a7da436) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 26, 2012

## Related Companies

- [Aurorium LLC](https://www.globalkeysolutions.net/companies/aurorium-llc/be33974b-e9e5-4d3e-9e45-52348f2d23d3)
- [Ames Goldsmith Corporation](https://www.globalkeysolutions.net/companies/ames-goldsmith-corporation/0c9c7a1f-10cc-4a11-9136-632fc42dbd63)
- [Alps Pharmaceutical Industrial Co., Ltd.](https://www.globalkeysolutions.net/companies/alps-pharmaceutical-industrial-co-ltd/d68f79f1-c4d0-4161-93c1-5f9a0cbd6d05)
- [Alembic Pharmaceuticals Limited (Units I and II)](https://www.globalkeysolutions.net/companies/alembic-pharmaceuticals-limited-units-i-and-ii/68fd4724-f974-4ddc-8882-a5d28dc90916)
- [Chifeng Pharmaceutical Company, Ltd.](https://www.globalkeysolutions.net/companies/chifeng-pharmaceutical-company-ltd/3b71193c-338c-4461-ba6b-51e9f1b9711a)
- [La Crosse Milling Co.](https://www.globalkeysolutions.net/companies/la-crosse-milling-co/5f2c8229-ee30-4508-8b49-84f0a6d926f9)
- [Megafine Pharma (P) Limited](https://www.globalkeysolutions.net/companies/megafine-pharma-p-limited/47f3a083-30b0-4f15-ac09-3f99d5e75442)
- [NTP Radioisotopes](https://www.globalkeysolutions.net/companies/ntp-radioisotopes/403d138e-310f-4568-9b6e-e37ea2081d37)
- [Zhejiang Lepu Pharmaceutical Co., Ltd.](https://www.globalkeysolutions.net/companies/zhejiang-lepu-pharmaceutical-co-ltd/3f04f71b-33ea-46db-b25c-d115b2c88686)
- [Symed Labs Limited (Unit I)](https://www.globalkeysolutions.net/companies/symed-labs-limited-unit-i/6687f07e-a946-4527-86e8-687f0ec46c66)

## Related Officers

- [Dennis Cantellops Paite](https://www.globalkeysolutions.net/people/dennis-cantellops-paite/3336bbb8-8520-4a8a-9085-76e7a55ca773)